XML 100 R85.htm IDEA: XBRL DOCUMENT v3.6.0.2
Condensed Consolidating Financial Statements (Condensed Consolidating Statement of Cash Flows) (Details) - USD ($)
$ in Thousands
 1 Months Ended 3 Months Ended 9 Months Ended
Dec. 31, 2016
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2016
Dec. 31, 2015
Operating Activities          
Net income (loss)   $ 31,641 $ 27,995 $ 58,305 $ 85,971
Adjustments to reconcile net income (loss) to net cash provided by operating activities:          
Depreciation and amortization       18,700 17,478
Loss on divestitures and sales of property and equipment       51,807 0
Deferred income taxes       (12,530) 31,591
Amortization of debt origination costs       6,129 5,433
Stock-based compensation costs       6,260 7,098
Loss on extinguishment of debt   0 0 0 451
Gain on sale or disposal of property and equipment       0 (36)
Equity in income of subsidiaries       0 0
Changes in operating assets and liabilities, net of effects from acquisitions:          
Accounts receivable       (12,374) 2,453
Inventories       (16,589) (7,114)
Prepaid expenses and other current assets       11,149 5,472
Accounts payable       7,168 (17,553)
Accrued liabilities       22,323 5,207
Net cash provided by operating activities       140,348 136,451
Investing Activities          
Purchases of property and equipment       (1,935) (2,540)
Proceeds from sale of business       110,717 0
Proceeds from the sales of property and equipment       85 344
Net cash provided by investing activities       110,286 5,041
Financing Activities          
Term loan repayments       (130,500) (50,000)
Borrowings under revolving credit agreement       20,000 15,000
Repayments under revolving credit agreement       (105,000) (81,100)
Payments of debt origination costs       (9) (4,211)
Proceeds from exercise of stock options       3,444 6,600
Proceeds from restricted stock exercises       0 544
Excess tax benefits from share-based awards       800 1,850
Fair value of shares surrendered as payment of tax withholding       (1,431) (2,187)
Intercompany activity, net       0 0
Net cash used in financing activities       (212,696) (113,504)
Effects of exchange rate changes on cash and cash equivalents       (1,879) (333)
Increase in cash and cash equivalents       36,059 27,655
Cash and cash equivalents - beginning of period       27,230 21,318
Cash and cash equivalents - end of period $ 63,289 63,289 48,973 63,289 48,973
Prestige Brands Holdings, Inc.          
Operating Activities          
Net income (loss)   31,641 27,995 58,305 85,971
Adjustments to reconcile net income (loss) to net cash provided by operating activities:          
Depreciation and amortization       2,474 3,032
Loss on divestitures and sales of property and equipment        
Deferred income taxes       (2,056) 148
Amortization of debt origination costs       0 0
Stock-based compensation costs       6,260 7,057
Loss on extinguishment of debt         0
Gain on sale or disposal of property and equipment         0
Equity in income of subsidiaries       (59,111) (84,458)
Changes in operating assets and liabilities, net of effects from acquisitions:          
Accounts receivable       0 0
Inventories       0 0
Prepaid expenses and other current assets       11,200 3,557
Accounts payable       (118) (33)
Accrued liabilities       1,437 (102)
Net cash provided by operating activities       18,391 15,172
Investing Activities          
Purchases of property and equipment       (890) (1,741)
Proceeds from sale of business       0  
Proceeds from the sales of property and equipment       0 0
Net cash provided by investing activities       (890) (1,741)
Financing Activities          
Term loan repayments       0 0
Borrowings under revolving credit agreement       0 0
Repayments under revolving credit agreement       0 0
Payments of debt origination costs       0 0
Proceeds from exercise of stock options       3,444 6,600
Proceeds from restricted stock exercises         544
Excess tax benefits from share-based awards       800 1,850
Fair value of shares surrendered as payment of tax withholding       (1,431) (2,187)
Intercompany activity, net       12,067 2,127
Net cash used in financing activities       14,880 8,934
Effects of exchange rate changes on cash and cash equivalents       0 0
Increase in cash and cash equivalents       32,381 22,365
Cash and cash equivalents - beginning of period       4,440 11,387
Cash and cash equivalents - end of period 36,821 36,821 33,752 36,821 33,752
Prestige Brands, Inc., the issuer          
Operating Activities          
Net income (loss)   33,252 25,153 59,193 78,127
Adjustments to reconcile net income (loss) to net cash provided by operating activities:          
Depreciation and amortization       456 444
Loss on divestitures and sales of property and equipment       0  
Deferred income taxes       493 164
Amortization of debt origination costs       6,129 5,433
Stock-based compensation costs       0 0
Loss on extinguishment of debt         451
Gain on sale or disposal of property and equipment         0
Equity in income of subsidiaries       (37,390) (52,599)
Changes in operating assets and liabilities, net of effects from acquisitions:          
Accounts receivable       (266) 1,158
Inventories       (7,347) (2,519)
Prepaid expenses and other current assets       99 (305)
Accounts payable       1,775 (1,161)
Accrued liabilities       742 (1,636)
Net cash provided by operating activities       23,884 27,557
Investing Activities          
Purchases of property and equipment       (158) (93)
Proceeds from sale of business       0  
Proceeds from the sales of property and equipment       0 0
Net cash provided by investing activities       (158) (93)
Financing Activities          
Term loan repayments       (130,500) (50,000)
Borrowings under revolving credit agreement       20,000 15,000
Repayments under revolving credit agreement       (105,000) (81,100)
Payments of debt origination costs       (9) (4,211)
Proceeds from exercise of stock options       0 0
Proceeds from restricted stock exercises         0
Excess tax benefits from share-based awards       0 0
Fair value of shares surrendered as payment of tax withholding       0 0
Intercompany activity, net       191,783 92,847
Net cash used in financing activities       (23,726) (27,464)
Effects of exchange rate changes on cash and cash equivalents       0 0
Increase in cash and cash equivalents       0 0
Cash and cash equivalents - beginning of period       0 0
Cash and cash equivalents - end of period 0 0 0 0 0
Combined Subsidiary Guarantors          
Operating Activities          
Net income (loss)   23,286 18,147 37,481 58,860
Adjustments to reconcile net income (loss) to net cash provided by operating activities:          
Depreciation and amortization       15,410 13,686
Loss on divestitures and sales of property and equipment       51,807  
Deferred income taxes       (11,101) 31,301
Amortization of debt origination costs       0 0
Stock-based compensation costs       0 0
Loss on extinguishment of debt         0
Gain on sale or disposal of property and equipment         0
Equity in income of subsidiaries       (8,766) (6,868)
Changes in operating assets and liabilities, net of effects from acquisitions:          
Accounts receivable       (5,481) 2,188
Inventories       (9,409) (3,014)
Prepaid expenses and other current assets       (525) 2,752
Accounts payable       5,981 (14,613)
Accrued liabilities       20,995 5,439
Net cash provided by operating activities       96,392 89,731
Investing Activities          
Purchases of property and equipment       (785) (212)
Proceeds from sale of business       110,717  
Proceeds from the sales of property and equipment       85 0
Net cash provided by investing activities       111,436 7,025
Financing Activities          
Term loan repayments       0 0
Borrowings under revolving credit agreement       0 0
Repayments under revolving credit agreement       0 0
Payments of debt origination costs       0 0
Proceeds from exercise of stock options       0 0
Proceeds from restricted stock exercises         0
Excess tax benefits from share-based awards       0 0
Fair value of shares surrendered as payment of tax withholding       0 0
Intercompany activity, net       (210,525) (96,756)
Net cash used in financing activities       (210,525) (96,756)
Effects of exchange rate changes on cash and cash equivalents       0 0
Increase in cash and cash equivalents       (2,697) 0
Cash and cash equivalents - beginning of period       2,899 0
Cash and cash equivalents - end of period 202 202 0 202 0
Combined Non- Guarantor Subsidiaries          
Operating Activities          
Net income (loss)   2,089 2,033 8,766 6,868
Adjustments to reconcile net income (loss) to net cash provided by operating activities:          
Depreciation and amortization       360 316
Loss on divestitures and sales of property and equipment       0  
Deferred income taxes       134 (22)
Amortization of debt origination costs       0 0
Stock-based compensation costs       0 41
Loss on extinguishment of debt         0
Gain on sale or disposal of property and equipment         (36)
Equity in income of subsidiaries       0 0
Changes in operating assets and liabilities, net of effects from acquisitions:          
Accounts receivable       (6,627) (893)
Inventories       (6) (1,511)
Prepaid expenses and other current assets       375 (532)
Accounts payable       (470) (1,746)
Accrued liabilities       (851) 1,506
Net cash provided by operating activities       1,681 3,991
Investing Activities          
Purchases of property and equipment       (102) (494)
Proceeds from sale of business       0  
Proceeds from the sales of property and equipment       0 344
Net cash provided by investing activities       (102) (150)
Financing Activities          
Term loan repayments       0 0
Borrowings under revolving credit agreement       0 0
Repayments under revolving credit agreement       0 0
Payments of debt origination costs       0 0
Proceeds from exercise of stock options       0 0
Proceeds from restricted stock exercises         0
Excess tax benefits from share-based awards       0 0
Fair value of shares surrendered as payment of tax withholding       0 0
Intercompany activity, net       6,675 1,782
Net cash used in financing activities       6,675 1,782
Effects of exchange rate changes on cash and cash equivalents       (1,879) (333)
Increase in cash and cash equivalents       6,375 5,290
Cash and cash equivalents - beginning of period       19,891 9,931
Cash and cash equivalents - end of period 26,266 26,266 15,221 26,266 15,221
Eliminations          
Operating Activities          
Net income (loss)   (58,627) (45,333) (105,440) (143,855)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:          
Depreciation and amortization       0 0
Loss on divestitures and sales of property and equipment       0  
Deferred income taxes       0 0
Amortization of debt origination costs       0 0
Stock-based compensation costs       0 0
Loss on extinguishment of debt         0
Gain on sale or disposal of property and equipment         0
Equity in income of subsidiaries       105,267 143,925
Changes in operating assets and liabilities, net of effects from acquisitions:          
Accounts receivable       0 0
Inventories       173 (70)
Prepaid expenses and other current assets       0 0
Accounts payable       0 0
Accrued liabilities       0 0
Net cash provided by operating activities       0 0
Investing Activities          
Purchases of property and equipment       0 0
Proceeds from sale of business       0  
Proceeds from the sales of property and equipment       0 0
Net cash provided by investing activities       0 0
Financing Activities          
Term loan repayments       0 0
Borrowings under revolving credit agreement       0 0
Repayments under revolving credit agreement       0 0
Payments of debt origination costs       0 0
Proceeds from exercise of stock options       0 0
Proceeds from restricted stock exercises         0
Excess tax benefits from share-based awards       0 0
Fair value of shares surrendered as payment of tax withholding       0 0
Intercompany activity, net       0 0
Net cash used in financing activities       0 0
Effects of exchange rate changes on cash and cash equivalents       0 0
Increase in cash and cash equivalents       0 0
Cash and cash equivalents - beginning of period       0 0
Cash and cash equivalents - end of period 0 $ 0 $ 0 0 0
DenTek Oral Care, Inc.          
Investing Activities          
Proceeds from previous acquisitions $ 1,400     1,419 0
DenTek Oral Care, Inc. | Prestige Brands Holdings, Inc.          
Investing Activities          
Proceeds from previous acquisitions       0  
DenTek Oral Care, Inc. | Prestige Brands, Inc., the issuer          
Investing Activities          
Proceeds from previous acquisitions       0  
DenTek Oral Care, Inc. | Combined Subsidiary Guarantors          
Investing Activities          
Proceeds from previous acquisitions       1,419  
DenTek Oral Care, Inc. | Combined Non- Guarantor Subsidiaries          
Investing Activities          
Proceeds from previous acquisitions       0  
DenTek Oral Care, Inc. | Eliminations          
Investing Activities          
Proceeds from previous acquisitions       0  
Insight Pharmaceuticals          
Investing Activities          
Proceeds from previous acquisitions       $ 0 7,237
Insight Pharmaceuticals | Prestige Brands Holdings, Inc.          
Investing Activities          
Proceeds from previous acquisitions         0
Insight Pharmaceuticals | Prestige Brands, Inc., the issuer          
Investing Activities          
Proceeds from previous acquisitions         0
Insight Pharmaceuticals | Combined Subsidiary Guarantors          
Investing Activities          
Proceeds from previous acquisitions         7,237
Insight Pharmaceuticals | Combined Non- Guarantor Subsidiaries          
Investing Activities          
Proceeds from previous acquisitions         0
Insight Pharmaceuticals | Eliminations          
Investing Activities          
Proceeds from previous acquisitions         $ 0